SYNTHESIS OF A FLUORESCENT DERIVATIVE OF CYCLOSPORINE-A FOR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ANALYSIS

被引:10
作者
FOIS, RA [1 ]
ASHLEY, JJ [1 ]
机构
[1] UNIV SYDNEY,DEPT PHARM,SYDNEY,NSW 2006,AUSTRALIA
关键词
D O I
10.1002/jps.2600800416
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A direct assay method for use in studies of cyclosporin binding must be highly sensitive and selective since it must be capable of measuring the concentrations encountered in the protein-free matrix. The failure of current HPLC methods to achieve the sensitivity required for binding studies may be attributed to the use of UV detection, which relies on the relatively weak end-absorption of cyclosporin A. A method involving fluorescence derivatization was sought with the aim of increasing HPLC assay sensitivity. A method is described for producing a fluorescent derivative of cyclosporin A, a compound which has no functional groups which are easily derivatized. However, intramolecular rearrangement of cyclosporin A to form its structural isomer, isocyclosporin A, exposes a secondary amine which can be reacted with dansyl chloride to produce a fluorescent derivative. This two-step derivatization procedure was used as the basis of an HPLC fluorescence assay. Although this assay is not sufficiently sensitive to measure concentrations encountered in the protein-free matrix during plasma binding studies, the method does point to the possible development of a more sensitive assay using a derivatizing reagent other than dansyl chloride.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 13 条
[1]   IMPORTANCE OF RADIOCHEMICAL PURITY OF RADIOLABELED DRUGS USED FOR DETERMINING PLASMA-PROTEIN BINDING OF DRUGS [J].
BJORNSSON, TD ;
BROWN, JE ;
TSCHANZ, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (12) :1372-1373
[2]   CYCLOSPORINE, LOW-DENSITY LIPOPROTEIN, AND CHOLESTEROL [J].
DEGROEN, PC .
MAYO CLINIC PROCEEDINGS, 1988, 63 (10) :1012-1021
[4]   3,4-DIHYDRO-6,7-DIMETHOXY-4-METHYL-3-OXO-QUINOXALINE-2-CARBONYL CHLORIDE AS A HIGHLY SENSITIVE FLUORESCENCE DERIVATIZATION REAGENT FOR ALCOHOLS IN HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
IWATA, T ;
YAMAGUCHI, M ;
HARA, S ;
NAKAMURA, M ;
OHKURA, Y .
JOURNAL OF CHROMATOGRAPHY, 1986, 362 (02) :209-216
[5]   CYCLOSPORINE - MEASUREMENT OF FRACTION UNBOUND IN PLASMA [J].
LEGG, B ;
ROWLAND, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (08) :599-603
[6]   ROLE OF LIPOPROTEINS AND ERYTHROCYTES IN THE INVITRO BINDING AND DISTRIBUTION OF CYCLOSPORIN-A IN THE BLOOD [J].
LEMAIRE, M ;
TILLEMENT, JP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (11) :715-718
[7]   RATIONALE FOR MONITORING FREE DRUG LEVELS [J].
LEVY, RH ;
MORELAND, TA .
CLINICAL PHARMACOKINETICS, 1984, 9 :1-9
[8]  
MRAZ W, 1983, TRANSPL P, V15, P2426
[9]   CYCLOSPORINE-ASSOCIATED CHRONIC NEPHROPATHY [J].
MYERS, BD ;
ROSS, J ;
NEWTON, L ;
LUETSCHER, J ;
PERLROTH, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (11) :699-705
[10]  
Prevost C, 1933, CR HEBD ACAD SCI, V196, P1129